Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2004 1
2005 3
2007 2
2008 5
2009 2
2010 3
2011 2
2012 4
2013 3
2014 7
2015 5
2016 8
2017 10
2018 11
2019 11
2020 13
2021 15
2022 9
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Rowin EJ, Maron MS, Sherrid MV. Maron BJ, et al. J Am Coll Cardiol. 2022 Feb 1;79(4):372-389. doi: 10.1016/j.jacc.2021.12.002. J Am Coll Cardiol. 2022. PMID: 35086660 Free article.
Family screening with noninvasive imaging will identify relatives with the HCM phenotype, while genetic analysis recognizes preclinical sarcomere gene carriers without left ventricular hypertrophy, but with the potential to transmit disease. ...
Family screening with noninvasive imaging will identify relatives with the HCM phenotype, while genetic analysis recognizes preclinical sarc …
Insulin resistance in chronic kidney disease: a systematic review.
Spoto B, Pisano A, Zoccali C. Spoto B, et al. Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1087-F1108. doi: 10.1152/ajprenal.00340.2016. Epub 2016 Oct 5. Am J Physiol Renal Physiol. 2016. PMID: 27707707 Free article. Review.
IR has been solidly associated with intermediate mechanisms leading to cardiovascular (CV) disease in CKD including left ventricular hypertrophy, vascular dysfunction, and atherosclerosis. ...
IR has been solidly associated with intermediate mechanisms leading to cardiovascular (CV) disease in CKD including left ventricul …
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P. Monticone S, et al. Lancet Diabetes Endocrinol. 2018 Jan;6(1):41-50. doi: 10.1016/S2213-8587(17)30319-4. Epub 2017 Nov 9. Lancet Diabetes Endocrinol. 2018. PMID: 29129575 Review.
Similarly, primary aldosteronism increased the risk of diabetes (OR 1.33, 95% CI 1.01-1.74), metabolic syndrome (1.53, 1.22-1.91), and left ventricular hypertrophy (2.29, 1.65-3.17). INTERPRETATION: Diagnosing primary aldosteronism in the early stages of dise …
Similarly, primary aldosteronism increased the risk of diabetes (OR 1.33, 95% CI 1.01-1.74), metabolic syndrome (1.53, 1.22-1.91), and le …
Pharmacotherapy for hypertension-induced left ventricular hypertrophy.
Leache L, Gutiérrez-Valencia M, Finizola RM, Infante E, Finizola B, Pardo Pardo J, Flores Y, Granero R, Arai KJ. Leache L, et al. Cochrane Database Syst Rev. 2021 Oct 10;10(10):CD012039. doi: 10.1002/14651858.CD012039.pub3. Cochrane Database Syst Rev. 2021. PMID: 34628642 Free PMC article. Review.
BACKGROUND: Hypertension is the leading preventable risk factor for cardiovascular disease and premature death worldwide. One of the clinical effects of hypertension is left ventricular hypertrophy (LVH), a process of cardiac remodelling. ...
BACKGROUND: Hypertension is the leading preventable risk factor for cardiovascular disease and premature death worldwide. One of the clinica …
Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies.
Cuspidi C, Rescaldani M, Sala C, Grassi G. Cuspidi C, et al. J Hypertens. 2014 Jan;32(1):16-25. doi: 10.1097/HJH.0b013e328364fb58. J Hypertens. 2014. PMID: 24309485 Review.
AIM: Left-ventricular hypertrophy (LVH) is a frequent complication in obese individuals; an updated review and meta-analysis focusing on this issue is lacking. ...DESIGN: A literature search using the keywords 'left ventricle', 'left-ventricular …
AIM: Left-ventricular hypertrophy (LVH) is a frequent complication in obese individuals; an updated review and meta-ana …
Left ventricular hypertrophy and cognitive function: a systematic review.
Restrepo C, Patel SK, Rethnam V, Werden E, Ramchand J, Churilov L, Burrell LM, Brodtmann A. Restrepo C, et al. J Hum Hypertens. 2018 Mar;32(3):171-179. doi: 10.1038/s41371-017-0023-0. Epub 2018 Jan 12. J Hum Hypertens. 2018. PMID: 29330420
Cognitive impairment is common in patients with hypertension. Left ventricular hypertrophy (LVH) is recognised as a marker of hypertension-related organ damage and is a strong predictor of coronary artery disease, heart failure and stroke. ...Independent sear …
Cognitive impairment is common in patients with hypertension. Left ventricular hypertrophy (LVH) is recognised as a mar …
Left ventricular hypertrophy in association with cognitive impairment: a systematic review and meta-analysis.
Georgakis MK, Synetos A, Mihas C, Karalexi MA, Tousoulis D, Seshadri S, Petridou ET. Georgakis MK, et al. Hypertens Res. 2017 Jul;40(7):696-709. doi: 10.1038/hr.2017.11. Epub 2017 Feb 16. Hypertens Res. 2017. PMID: 28202945 Review.
Left ventricular hypertrophy (LVH) is a marker of prolonged exposure to high blood pressure and a predictor of cardiovascular disease risk. ...
Left ventricular hypertrophy (LVH) is a marker of prolonged exposure to high blood pressure and a predictor of cardiova …
Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
Chung J, Robinson C, Sheffield L, Paramanathan P, Yu A, Ewusie J, Sanger S, Mitsnefes M, Parekh RS, Sinha MD, Rodrigues M, Thabane L, Dionne J, Chanchlani R. Chung J, et al. Hypertension. 2023 Nov;80(11):2280-2292. doi: 10.1161/HYPERTENSIONAHA.123.20967. Epub 2023 Sep 22. Hypertension. 2023. PMID: 37737026 Review.
Hypertension is a risk factor for subclinical cardiovascular outcomes, including left ventricular hypertrophy, increased left ventricular mass index, carotid intima media thickness, and pulse wave velocity. ...Pediatric MH prevalence was stratified by disease …
Hypertension is a risk factor for subclinical cardiovascular outcomes, including left ventricular hypertrophy, increase …
Renal denervation for resistant hypertension.
Pisano A, Iannone LF, Leo A, Russo E, Coppolino G, Bolignano D. Pisano A, et al. Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD011499. doi: 10.1002/14651858.CD011499.pub3. Cochrane Database Syst Rev. 2021. PMID: 34806762 Free PMC article. Review.
OBJECTIVES: We sought to evaluate the short- and long-term effects of renal denervation in individuals with resistant hypertension on clinical end points, including fatal and non-fatal cardiovascular events, all-cause mortality, hospital admissions, quality of life, blood pressur …
OBJECTIVES: We sought to evaluate the short- and long-term effects of renal denervation in individuals with resistant hypertension on clinic …
118 results